(Q40253264)

18 September 2017

Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis (English)

1 reference

18 September 2017

Shuji Mikami

1

1 reference

18 September 2017

Mototsugu Oya

2

1 reference

18 September 2017

Ryuichi Mizuno

3

1 reference

18 September 2017

Masaru Murai

4

1 reference

18 September 2017

Makio Mukai

5

1 reference

18 September 2017

Yasunori Okada

6

1 reference

18 September 2017

13 July 2006

1 reference

18 September 2017

1 reference

18 September 2017

97

1 reference

18 September 2017

9

1 reference

18 September 2017

875-882

1 reference

Targeting HIF-1 for cancer therapy

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Expression of vascular endothelial growth factor in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

21 January 2018

Focus on kidney cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Microvessel density in renal cell carcinoma: lack of prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

Systemic therapy for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00268.X

10.1111/J.1349-7006.2006.00268.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference